Unraveling the Impact of Pneumococcal Conjugate Vaccines on Ambulatory Antibiotic Drug Consumption in Young Children: An Interrupted Time-Series Analysis.
Dana DaninoBart Adriaan van der BeekNoga Givon-LaviDavid GreenbergShalom Ben-ShimolRon DaganPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Shortly following PCV implementation, overall DAP rates showed an abrupt, steep decline, stabilizing within 5 years, in parallel to post-PCV respiratory infection trends previously described in this population, suggesting causality. The variable patterns of certain drug categories suggest additional influences beyond PCV.